Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › MS › Biloxi › NPI 1972557064
Hospital

Biloxi Hma LLC

Biloxi Hma LLC was paid $25.71M by Medicaid between Jan 2018 and Dec 2024, across 240 billing codes. Its largest line is 99283, emergency room visit (moderate) — 17% of everything it billed.

33Billing provider infoBILOXI HMA LLC
BILOXI, MS 39530
33aNPI1972557064assigned 05/22/2006
28Total paid$25.71M
24GClaims727,259
24DCodes billed240
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Mississippi

Rank by total paid#20 of 77
Median peer was paid$8.23M
This provider vs. median3.1×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official NOONAN, PEGGY controls 18+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018112,507$3.91M
2019109,256$4.18M
202086,107$3.05M
2021104,539$3.90M
2022118,872$4.01M
2023124,657$4.13M
2024incomplete71,321$2.53M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 17% 34,350 26,581 $4.43M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 14% 20,125 15,581 $3.49M
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 8.1% 4,742 4,069 $2.08M
G0378 Hospital observation service, per hour 4.7% 4,182 2,382 $1.22M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 4.6% 5,740 4,459 $1.17M
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 3.7% 11,463 8,541 $963K
88305 Level IV - Surgical pathology, gross and microscopic examination 3.7% 7,775 6,100 $960K
99282 Emergency department visit for the evaluation and management, low to moderate severity 2.7% 8,589 7,116 $702K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder 2.0% 9,675 2,054 $527K
74177 Computed tomography, abdomen and pelvis; with contrast material 2.0% 2,902 2,382 $504K
99281 Emergency department visit for the evaluation and management, self-limited or minor 1.9% 10,736 8,775 $498K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.9% 5,686 3,777 $493K
228 more codes
45380 Colonoscopy, flexible; with biopsy, single or multiple 1.5% 669 $387K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 1.5% 10,836 $380K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 1.4% 3,855 $358K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 1.3% 12,532 $345K
96361 Intravenous infusion, hydration; each additional hour 1.3% 7,443 $327K
71046 Radiologic examination, chest; 2 views 1.2% 7,707 $317K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 1.2% 8,000 $314K
71045 Radiologic examination, chest; single view 1.2% 9,249 $313K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 1.2% 3,243 $308K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 1.1% 13,732 $280K
70450 Computed tomography, head or brain; without contrast material <1% 4,925 $256K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 5,980 $241K
80053 Comprehensive metabolic panel <1% 29,378 $210K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 15,347 $210K
96375 Therapeutic injection; each additional sequential IV push <1% 8,663 $207K
88312 <1% 5,227 $176K
86900 <1% 4,662 $176K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 32,695 $176K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 1,568 $168K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 5,633 $154K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 10,284 $150K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 879 $132K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 4,730 $128K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 4,730 $127K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 10,805 $124K
36415 Collection of venous blood by venipuncture <1% 51,374 $112K
74018 <1% 2,006 $90K
86850 <1% 4,546 $77K
D2930 Prefabricated stainless steel crown - primary tooth <1% 1,197 $75K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 2,021 $72K
59025 Fetal non-stress test <1% 780 $68K
83880 <1% 3,649 $66K
87070 <1% 9,724 $65K
86901 <1% 5,043 $61K
81025 <1% 10,749 $61K
84484 <1% 8,316 $58K
87086 Culture, bacterial; quantitative colony count, urine <1% 10,058 $57K
87420 <1% 5,284 $57K
84443 Thyroid stimulating hormone (TSH) <1% 4,597 $54K
77067 Screening mammography, bilateral, including computer-aided detection <1% 630 $52K
88142 <1% 3,194 $50K
81382 <1% 732 $47K
73630 <1% 1,138 $45K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 524 $44K
D3220 Therapeutic pulpotomy (excluding final restoration) - removal of pulp coronal to the dentinocemental junction <1% 876 $42K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 1,904 $42K
88304 <1% 866 $41K
81376 <1% 687 $40K
80055 <1% 1,088 $39K
73610 <1% 894 $39K
90853 Group psychotherapy (other than of a multiple-family group) <1% 1,190 $39K
73562 <1% 1,036 $38K
87806 <1% 2,159 $38K
72125 Computed tomography, cervical spine; without contrast material <1% 877 $38K
99213 Doctor's office visit, returning patient (routine) <1% 1,271 $37K
83516 <1% 1,663 $36K
81003 <1% 23,028 $35K
84702 <1% 3,328 $35K
80048 Basic metabolic panel (calcium, ionized) <1% 5,781 $35K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 505 $32K
87040 <1% 3,895 $31K
72100 <1% 627 $30K
83690 <1% 6,068 $28K
73130 <1% 705 $28K
73221 <1% 197 $25K
83735 <1% 6,640 $25K
85027 <1% 4,878 $24K
80061 Lipid panel <1% 2,315 $24K
87186 <1% 3,710 $23K
92526 <1% 371 $22K
73030 <1% 576 $21K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 154 $20K
99214 Doctor's office visit, returning patient (more involved) <1% 450 $20K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 1,272 $19K
82553 <1% 3,260 $18K
82550 <1% 4,722 $18K
J0561 Injection, penicillin g benzathine, 100,000 units <1% 177 $18K
84439 <1% 2,933 $17K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 714 $17K
85730 <1% 5,100 $17K
73110 <1% 412 $16K
82077 <1% 1,506 $15K
87088 <1% 2,672 $14K
86140 <1% 3,795 $14K
83605 <1% 2,126 $14K
85610 <1% 5,806 $14K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 1,991 $13K
83036 Hemoglobin; glycosylated (A1C) <1% 1,850 $12K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 176 $11K
76641 <1% 150 $10K
82962 <1% 5,877 $10K
80143 <1% 876 $9K
87077 <1% 1,751 $9K
80179 <1% 841 $9K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 157 $8K
87427 <1% 901 $8K
83630 <1% 523 $8K
83993 <1% 511 $8K
87899 <1% 880 $8K
86738 <1% 742 $8K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 428 $8K
82248 <1% 1,842 $7K
85651 <1% 1,762 $7K
87147 <1% 1,730 $7K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 134 $7K
76830 Ultrasound, transvaginal <1% 90 $7K
86803 <1% 824 $7K
87045 <1% 904 $7K
82105 <1% 527 $6K
82784 <1% 877 $6K
87428 <1% 176 $6K
86780 <1% 711 $6K
87205 <1% 1,703 $6K
82677 <1% 297 $6K
85378 <1% 1,049 $6K
87177 <1% 777 $5K
78227 <1% 15 $5K
72141 <1% 54 $5K
82247 <1% 1,290 $5K
87081 <1% 978 $5K
87329 <1% 512 $5K
12011 <1% 46 $5K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 193 $5K
82607 <1% 389 $4K
87324 <1% 442 $4K
86336 <1% 297 $4K
D2934 <1% 36 $4K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 100 $4K
97116 <1% 261 $3K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring <1% 13 $3K
93971 <1% 82 $3K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 36 $3K
36600 <1% 52 $3K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 33 $3K
84703 <1% 565 $3K
81002 <1% 1,293 $3K
82950 <1% 679 $3K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 4,720 $2K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 3,925 $2K
73502 <1% 84 $2K
76819 Fetal biophysical profile; without non-stress testing <1% 29 $2K
92523 <1% 12 $2K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 6,558 $2K
J7030 Infusion, normal saline solution , 1000 cc <1% 9,392 $2K
72040 <1% 41 $2K
82947 <1% 552 $2K
96376 <1% 3,105 $2K
85007 <1% 448 $1K
12001 <1% 13 $1K
29125 <1% 23 $1K
76801 <1% 14 $1K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 16 $994.34
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 5,015 $958.56
77066 Tomosynthesis, mammo <1% 16 $941.58
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 663 $891.33
82803 <1% 53 $831.52
71250 <1% 28 $790.80
97162 <1% 33 $784.27
77065 Tomosynthesis, mammo <1% 12 $688.81
86703 <1% 61 $686.96
97010 <1% 143 $565.85
J7121 5% dextrose in lactated ringers infusion, up to 1000 cc <1% 2,766 $563.69
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 10,169 $562.14
87210 <1% 169 $557.81
82150 <1% 170 $516.00
83020 <1% 66 $413.77
J2270 Injection, morphine sulfate, up to 10 mg <1% 3,235 $395.19
82728 <1% 44 $381.45
83540 <1% 87 $379.71
87340 <1% 48 $298.23
86592 <1% 107 $262.47
84145 <1% 642 $193.62
Q9969 Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose <1% 50 $190.00
82951 <1% 18 $185.94
81001 <1% 103 $143.25
82565 <1% 30 $116.10
84100 <1% 35 $113.20
C9113 Injection, pantoprazole sodium, per vial <1% 327 $103.70
J1170 Injection, hydromorphone, up to 4 mg <1% 1,749 $101.96
J2704 Injection, propofol, 10 mg <1% 9,685 $96.78
J2550 Injection, promethazine hcl, up to 50 mg <1% 1,359 $87.24
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 1,935 $85.75
A9579 Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml <1% 347 $64.76
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 1,370 $60.64
83615 <1% 14 $60.04
90714 <1% 247 $59.84
82043 <1% 13 $47.43
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 1,795 $44.72
J3010 Injection, fentanyl citrate, 0.1 mg <1% 4,170 $24.86
J1940 Injection, furosemide, up to 20 mg <1% 297 $11.35
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 961 $10.03
J7510 Prednisolone oral, per 5 mg <1% 380 $9.01
J7050 Infusion, normal saline solution, 250 cc <1% 1,383 $1.32
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 4,380 $1.20
J0330 Injection, succinylcholine chloride, up to 20 mg 0% 1,545 $0.00
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 0% 2,124 $0.00
J0690 Injection, cefazolin sodium, 500 mg 0% 2,705 $0.00
J7512 Prednisone, immediate release or delayed release, oral, 1 mg 0% 288 $0.00
J2060 Injection, lorazepam, 2 mg 0% 318 $0.00
J2360 Injection, orphenadrine citrate, up to 60 mg 0% 20 $0.00
J8540 Dexamethasone, oral, 0.25 mg 0% 13 $0.00
J0360 Injection, hydralazine hcl, up to 20 mg 0% 96 $0.00
J0131 Injection, acetaminophen, not otherwise specified,10 mg 0% 358 $0.00
J3490 Unclassified drugs 0% 243 $0.00
77063 Screening digital breast tomosynthesis, bilateral 0% 25 $0.00
80320 0% 60 $0.00
D0150 Comprehensive oral evaluation - new or established patient 0% 14 $0.00
J2003 Injection, lidocaine hydrochloride, 1 mg 0% 16 $0.00
J2805 Injection, sincalide, 5 micrograms 0% 15 $0.00
J1630 Injection, haloperidol, up to 5 mg 0% 86 $0.00
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units 0% 41 $0.00
G0283 Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care 0% 29 $0.00
J7120 Ringers lactate infusion, up to 1000 cc 0% 10,309 $0.00
94664 0% 32 $0.00
J3475 Injection, magnesium sulfate, per 500 mg 0% 200 $0.00
J1953 Injection, levetiracetam, 10 mg 0% 16 $0.00
A9577 Injection, gadobenate dimeglumine (multihance), per ml 0% 38 $0.00
J1650 Injection, enoxaparin sodium, 10 mg 0% 223 $0.00
J1644 Injection, heparin sodium, per 1000 units 0% 46 $0.00
A9537 Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries 0% 15 $0.00
G1002 Clinical decision support mechanism medcurrent, as defined by the medicare appropriate use criteria program 0% 75 $0.00
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg 0% 61 $0.00
J2919 Injection, methylprednisolone sodium succinate, 5 mg 0% 14 $0.00
Q0163 Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen 0% 49 $0.00
90715 0% 40 $0.00
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg 0% 51 $0.00
J1171 Injection, hydromorphone, 0.1 mg 0% 15 $0.00
J0780 Injection, prochlorperazine, up to 10 mg 0% 16 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialNOONAN, PEGGY (DIRECTOR, BUSINESS SERVICES)
Same official

Other billing entities under NOONAN, PEGGY

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.